Treatment of diseases using nalmefene and its analgos

Details for Australian Patent Application No. 2005282480 (hide)

Owner Jenken Biosciences, Inc.

Inventors Wu, Edwin S. C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005282480

PCT Pub. Number WO2006/029167

Priority 10/936,431 08.09.04 US

Filing date 6 September 2005

Wipo publication date 16 March 2006

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/029167 Priority application(s): WO2006/029167

1 April 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Treatment of diseases using nalmefene and its analgos

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282489-Cancer-testis antigens

2005282478-Method and structure for arresting/ preventing fires in titanium clad compositions